Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

BIOABioAge Labs, Inc.

Nasdaq · CIK 0001709941
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts210

Identity from submissions API

NameBioAge Labs, Inc.
CIK0001709941
TickersBIOA
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN474721157
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone510-806-1445
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
5885 HOLLIS STREET
SUITE 370
EMERYVILLE
CA
94608
CA
Mailing address
5885 HOLLIS STREET
SUITE 370
EMERYVILLE
CA
94608
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

158 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005290 005-94634 261559131 34 9732
2026-11-05 10-Q 10-Q 0001193125-26-450023 001-42279 261528071 34 11922215 1 1
2026-11-05 8-K 8-K 2.02,9.01 0001193125-26-450008 001-42279 261528006 34 416531 1 1
2026-10-02 8-K 8-K 8.01 0001193125-26-412300 001-42279 261436631 34 169899 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003686 005-94634 261279649 34 9629
2026-08-05 10-Q 10-Q 0001193125-26-335407 001-42279 261244577 34 11637118 1 1
2026-08-05 8-K 8-K 2.02,9.01 0001193125-26-335368 001-42279 261244505 34 405382 1 1
2026-07-01 4 xslF345X06/form4-07012026_080701.xml 0001836297-26-000005 37792
2026-06-30 144 xsl144X01/primary_doc.xml 0001959173-26-004979 001-42279 261140780 33 5042
2026-06-29 144 xsl144X01/primary_doc.xml 0001959173-26-004955 001-42279 261136240 33 4928
2026-06-12 4 xslF345X06/form4-06122026_080608.xml 0001840663-26-000002 5693
2026-06-12 4 xslF345X06/form4-06122026_080642.xml 0001771213-26-000004 5633
2026-06-12 4 xslF345X06/form4-06122026_080606.xml 0001245624-26-000002 5635
2026-06-12 4 xslF345X06/form4-06122026_080600.xml 0001253886-26-000006 5697
2026-06-12 4 xslF345X06/form4-06122026_080647.xml 0001573785-26-000003 5689
2026-06-12 4 xslF345X06/form4-06122026_080614.xml 0001184175-26-000002 5656
2026-06-12 8-K 8-K 5.07 0001193125-26-268518 001-42279 261084960 34 196126 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-226770 005-94634 26987627 34 346604
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-002218 005-94634 26985206 34 9659
2026-05-08 8-K 8-K 2.02,9.01 0001193125-26-213472 001-42279 26956315 34 451530 1 1
2026-05-08 10-Q 10-Q 0001193125-26-213466 001-42279 26956282 34 10632714 1 1
2026-04-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-001675 005-94634 26901045 34 10813
2026-04-24 4 xslF345X06/form4-04242026_080410.xml 0001120478-26-000013 7199
2026-04-21 ARS ARS 0001193125-26-166933 001-42279 26879828 34 3728274
2026-04-21 DEFA14A DEFA14A 0001193125-26-166751 001-42279 26879435 34 1112675
2026-04-21 DEF 14A DEF 14A 0001193125-26-166738 001-42279 26879393 34 11890617 1 1
2026-04-03 4 xslF345X06/form4-04032026_080407.xml 0001210905-26-000011 12775
2026-04-01 144 xsl144X01/primary_doc.xml 0001959173-26-002686 001-42279 26825595 33 6724
2026-03-24 S-3ASR S-3ASR 0001193125-26-121862 333-294568 26786549 33 1447921 1 1
2026-03-24 S-8 S-8 0001193125-26-121794 333-294564 26786234 33 460568 1 1
2026-03-24 10-K 10-K 0001193125-26-120873 001-42279 26784362 34 62579056 1 1
2026-03-24 8-K 8-K 2.02,7.01,9.01 0001193125-26-120864 001-42279 26784345 34 425459 1 1
2026-03-03 4 xslF345X05/form4-03032026_090341.xml 0001210905-26-000009 12644
2026-03-03 4 xslF345X05/form4-03032026_090347.xml 0001120478-26-000011 7062
2026-03-02 144 xsl144X01/primary_doc.xml 0001959173-26-001612 001-42279 26704231 33 7438
2026-02-19 4 xslF345X05/form4-02192026_090237.xml 0001210905-26-000007 5558
2026-02-19 4 xslF345X05/form4-02192026_090237.xml 0002036289-26-000002 8118
2026-02-19 4 xslF345X05/form4-02192026_090219.xml 0001120478-26-000009 5591
2026-02-19 4 xslF345X05/form4-02192026_090238.xml 0002032751-26-000010 5530
2026-02-19 4 xslF345X05/form4-02192026_090243.xml 0001836297-26-000002 5562
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-016626 005-94634 26644290 34 11435
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-001035 005-94634 26640033 34 9571
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002032751-26-000008 005-94634 26633135 34 8909
2026-02-03 4 xslF345X05/form4-02032026_090207.xml 0001210905-26-000005 12645
2026-02-03 4 xslF345X05/form4-02032026_090256.xml 0001120478-26-000007 7062
2026-02-02 144 xsl144X01/primary_doc.xml 0001959173-26-000500 001-42279 26586100 33 6822
2026-01-22 8-K 8-K 1.01,7.01,9.01 0001193125-26-019536 001-42279 26552182 34 863951 1 1
2026-01-22 424B5 424B5 0001193125-26-019530 333-290688 26552149 33 458803
2026-01-21 4 xslF345X05/form4-01212026_090153.xml 0001120478-26-000005 7062
2026-01-20 424B5 424B5 0001193125-26-016537 333-290688 26542776 33 460764
2026-01-20 8-K 8-K 7.01,8.01,9.01 0001193125-26-016046 001-42279 26541284 34 334187 1 1
2026-01-15 4 xslF345X05/form4-01152026_090117.xml 0001120478-26-000003 14788
2026-01-15 4 xslF345X05/form4-01152026_090111.xml 0002032751-26-000003 5325
2026-01-13 144 xsl144X01/primary_doc.xml 0001974078-26-000010 001-42279 26530515 33 4430
2026-01-13 144 xsl144X01/primary_doc.xml 0001959173-26-000287 001-42279 26530279 33 4472
2026-01-12 8-K 8-K 7.01,8.01,9.01 0001193125-26-009911 001-42279 26525014 34 339671 1 1
2026-01-06 4 xslF345X05/form4-01062026_090157.xml 0001210905-26-000002 13180
2026-01-02 144 xsl144X01/primary_doc.xml 0001959173-26-000027 001-42279 26501409 33 6208
2025-12-11 4 xslF345X05/form4-12112025_091211.xml 0001210905-25-000006 8790
2025-12-09 144 xsl144X01/primary_doc.xml 0001959173-25-007588 001-42279 251558044 33 5048
2025-12-05 4 xslF345X05/form4-12052025_111241.xml 0001210905-25-000004 9202
2025-12-04 144 xsl144X01/primary_doc.xml 0001959173-25-007518 001-42279 251550176 33 4419
2025-12-04 8-K 8-K 7.01,8.01,9.01 0001193125-25-307541 001-42279 251548390 34 329319 1 1
2025-11-06 10-Q 10-Q 0001193125-25-270012 001-42279 251459330 34 11077556 1 1
2025-11-06 8-K 8-K 2.02,9.01 0001193125-25-269986 001-42279 251459266 34 494429 1 1
2025-11-05 S-3/A S-3/A 0001193125-25-267111 333-290690 251454738 33 456351
2025-11-05 S-3/A S-3/A 0001193125-25-267108 333-290688 251454721 33 858078
2025-10-02 S-3 S-3 0001193125-25-228452 333-290690 251369822 33 756800 1 1
2025-10-02 S-3 S-3 0001193125-25-228414 333-290688 251369693 33 2153534 1 1
2025-08-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-078851 005-94634 251221987 34 15799
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-003432 005-94634 251217836 34 10390
2025-08-11 4 xslF345X05/form4-08112025_080820.xml 0001415889-25-021423 5547
2025-08-06 10-Q 10-Q 0000950170-25-104176 001-42279 251190356 34 10554578 1 1
2025-08-06 8-K 8-K 2.02,9.01 0000950170-25-104151 001-42279 251190198 34 492609 1 1
2025-06-09 4 xslF345X05/form4-06092025_080617.xml 0001415889-25-016296 5495
2025-06-09 4 xslF345X05/form4-06092025_080608.xml 0001415889-25-016293 5497
2025-06-09 4 xslF345X05/form4-06092025_080600.xml 0001415889-25-016286 5559
2025-06-09 4 xslF345X05/form4-06092025_080644.xml 0001415889-25-016283 5543
2025-06-09 4 xslF345X05/form4-06092025_080653.xml 0001415889-25-016281 5545
2025-06-09 8-K 8-K 5.07 0000950170-25-083746 001-42279 251034292 34 162628 1 1
2025-06-04 8-K 8-K 8.01 0000950170-25-081409 001-42279 251022067 34 168129 1 1
2025-05-06 10-Q 10-Q 0000950170-25-064552 001-42279 25917920 34 12085481 1 1
2025-05-06 8-K 8-K 2.02,9.01 0000950170-25-064547 001-42279 25917847 34 507236 1 1
2025-04-17 ARS ARS 0000950170-25-055400 001-42279 25847489 34 15963068
2025-04-17 DEFA14A DEFA14A 0000950170-25-055384 001-42279 25847392 34 1074537
2025-04-17 DEF 14A DEF 14A 0000950170-25-055371 001-42279 25847250 34 3993924
2025-03-20 S-8 S-8 0000950170-25-042779 333-285980 25757819 33 260202
2025-03-20 10-K 10-K 0000950170-25-042759 001-42279 25757360 34 85093278 1 1
2025-03-20 8-K 8-K 2.02,9.01 0000950170-25-042747 001-42279 25757226 34 481981 1 1
2025-03-10 4/A xslF345X05/form4a-03102025_080325.xml 0001415889-25-007506 5053
2025-03-10 4 xslF345X05/form4-03102025_080333.xml 0001415889-25-007505 4763
2025-02-25 4/A xslF345X05/form4a-02252025_090206.xml 0001415889-25-005496 6051
2025-02-20 4 xslF345X05/form4-02202025_090226.xml 0001415889-25-004867 5517
2025-02-20 4 xslF345X05/form4-02202025_090258.xml 0001415889-25-004864 5481
2025-02-20 4 xslF345X05/form4-02202025_090258.xml 0001415889-25-004859 5405
2025-02-20 4 xslF345X05/form4-02202025_090259.xml 0001415889-25-004857 5489
2025-02-20 4 xslF345X05/form4-02202025_090229.xml 0001415889-25-004854 5521
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-004265 005-94634 25631676 34 19449
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-001097 005-94634 25627268 34 10085
2024-12-20 4 xslF345X05/form4-12202024_091252.xml 0001415889-24-029962 5517
2024-11-14 SC 13G SC 13G 0001193125-24-258589 005-94634 241462566 34 135602
2024-11-12 SC 13G SC 13G 0001104659-24-116796 005-94634 241448414 34 55915
2024-11-07 10-Q 10-Q 0000950170-24-123445 001-42279 241436610 34 9992837 1 1
2024-11-07 8-K 8-K 2.02,9.01 0000950170-24-123437 001-42279 241436444 34 415641 1 1
2024-10-07 SC 13G SC 13G 0001104659-24-106678 005-94634 241358045 34 75780
2024-10-04 SC 13D SC 13D 0001104659-24-106374 005-94634 241355949 34 206894
2024-10-03 4 xslF345X05/form4-10032024_111046.xml 0001415889-24-024688 15557
2024-10-01 4 xslF345X05/form4.xml 0000929638-24-003363 15563
2024-09-30 SC 13D SC 13D 0001104659-24-104494 005-94634 241340978 34 132527
2024-09-27 4 xslF345X05/form4-09272024_080956.xml 0001415889-24-024047 25250
2024-09-27 4 xslF345X05/form4-09272024_080937.xml 0001415889-24-024046 12106
2024-09-27 4 xslF345X05/form4-09272024_080922.xml 0001415889-24-024045 8471
2024-09-27 4 xslF345X05/form4-09272024_080939.xml 0001415889-24-024044 20259
2024-09-27 4 xslF345X05/form4-09272024_080911.xml 0001415889-24-024043 8320
2024-09-27 4 xslF345X05/form4-09272024_080914.xml 0001415889-24-024042 8370
2024-09-27 4 xslF345X05/form4-09272024_080926.xml 0001415889-24-024041 8499
2024-09-27 4 xslF345X05/form4-09272024_080956.xml 0001415889-24-024040 11148
2024-09-27 8-K 8-K 1.01,3.02,9.01 0001193125-24-227949 001-42279 241334870 34 307447
2024-09-26 S-8 S-8 0001193125-24-227045 333-282352 241329729 33 108209
2024-09-26 424B4 424B4 0001193125-24-226927 333-281901 241329101 33 10498820
2024-09-25 SEC STAFF LETTER filename1.pdf 9999999997-24-003958 63115
2024-09-25 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-09-25 16:00:00 9999999995-24-002965 333-281901 241326045 33 1711
2024-09-25 3 xslF345X02/form3.xml 0000929638-24-003233 10817
2024-09-25 S-1MEF S-1MEF 0001193125-24-226258 333-282334 241325769 33 67851
2024-09-25 3 xslF345X02/form3-09252024_080953.xml 0001415889-24-023966 19587
2024-09-25 3 xslF345X02/form3-09252024_080946.xml 0001415889-24-023965 12715
2024-09-25 3 xslF345X02/form3-09252024_080929.xml 0001415889-24-023964 12483
2024-09-25 3 xslF345X02/form3-09252024_080919.xml 0001415889-24-023963 12662
2024-09-25 3 xslF345X02/form3-09252024_080907.xml 0001415889-24-023962 11470
2024-09-25 3 xslF345X02/form3-09252024_080947.xml 0001415889-24-023961 11595
2024-09-25 3 xslF345X02/form3-09252024_080922.xml 0001415889-24-023960 17151
2024-09-25 3 xslF345X02/form3-09252024_080907.xml 0001415889-24-023959 26532
2024-09-25 3 xslF345X02/form3-09252024_080947.xml 0001415889-24-023958 13539
2024-09-25 3 xslF345X02/form3-09252024_080938.xml 0001415889-24-023956 20116
2024-09-25 3 xslF345X02/form3-09252024_080914.xml 0001415889-24-023955 12859
2024-09-25 CERT 8A_Cert_BIOA.pdf 0001354457-24-000722 001-42279 241322351 34 221270
2024-09-25 CORRESP filename1.htm 0001193125-24-225162 17088
2024-09-25 S-1/A S-1/A 0001193125-24-225155 333-281901 241321225 33 10616462
2024-09-23 UPLOAD filename1.pdf 0000000000-24-010807 377-07253 42366
2024-09-23 CORRESP filename1.htm 0001193125-24-223657 11262
2024-09-23 CORRESP filename1.htm 0001193125-24-223652 7812
2024-09-18 CORRESP filename1.htm 0001193125-24-221393 21348
2024-09-18 8-A12B 8-A12B 0001193125-24-221377 001-42279 241307516 34 14324
2024-09-18 S-1/A S-1/A 0001193125-24-221367 333-281901 241307432 33 11808705
2024-09-12 CORRESP filename1.htm 0001193125-24-218258 60201
2024-09-06 UPLOAD filename1.pdf 0000000000-24-010129 377-07253 43613
2024-09-03 CORRESP filename1.htm 0001193125-24-212054 28351
2024-09-03 S-1 S-1 0001193125-24-212046 333-281901 241273943 33 13029580
2024-08-09 UPLOAD filename1.pdf 0000000000-24-009107 377-07253 42585
2024-08-05 DRSLTR filename1.htm 0000950123-24-007163 32160
2024-08-05 DRS/A filename1.htm 0000950123-24-007160 377-07253 241174844 33 10821049
2024-07-18 UPLOAD filename1.pdf 0000000000-24-008187 377-07253 45916
2024-07-03 DRSLTR filename1.htm 0000950123-24-006380 52186
2024-07-03 DRS/A filename1.htm 0000950123-24-006378 377-07253 241099946 33 10518276
2024-06-28 SEC STAFF LETTER filename1.pdf 9999999997-24-003067 80527
2024-06-28 UPLOAD filename1.pdf 0000000000-24-007317 377-07253 62914
2024-05-31 DRS filename1.htm 0000950123-24-006073 377-07253 241009308 33 11744133
2024-02-13 D xslFormDX01/primary_doc.xml 06b 0001709941-24-000002 021-505095 24624026 33 11588

Latest XBRL company facts

One latest value per concept from companyfacts (210 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 45.96M 2026-10-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
dei EntityPublicFloat Entity Public Float USD 112.70M 2025-06-30 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.89M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 565,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 1.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 692,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1.17M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 762.88M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 4.64M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 13.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 9.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap Assets Assets USD 367.65M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap AssetsCurrent Assets, Current USD 295.05M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 52.67M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 52.41M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 257.49M 2025-03-31 2025 Q1 10-Q 2025-05-06 0000950170-25-064552
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 52.67M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -136.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 52.41M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 31,690 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 12.22M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 45.95M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 45.95M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap CommonStockValue Common Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -83.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 4.63M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 500,000 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-213466
us-gaap DebtInstrumentFeeAmount Debt Instrument, Fee Amount USD 487,000 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123445
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 2,000 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap DeferredIncomeCurrent Deferred Income, Current USD 3.31M 2023-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042759
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 3.90M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 75.70M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 640,000 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 43.97M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 1.08M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 10.38M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 3.80M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 75.06M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap DeferredTaxLiabilitiesInvestments Deferred Tax Liabilities, Investments USD 26,000 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 589,000 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap Depreciation Depreciation USD 200,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap DepreciationNonproduction Depreciation, Nonproduction USD 213,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 164,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap DirectOperatingCosts Direct Operating Costs USD 52.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.84 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.84 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.228 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -0.007 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 420,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042759
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.006 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042759
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.03 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability Embedded Derivative, Fair Value of Embedded Derivative Liability USD 18.18M 2023-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042759
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 4.02M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -206,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -23,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 22.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -80.58M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -80.61M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -20,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 18.36M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 572,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -16.93M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 487,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 26,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -118,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 2.41M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -768,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -204,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -1.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD -11,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -24,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 5.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap InterestAndOtherIncome Interest and Other Income USD 10.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 40,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 46,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap InterestReceivable Interest Receivable USD 2.30M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.125 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042759
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 3.52M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 140,000 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 763,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 140,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 834,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 810,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 786,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 186,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 789,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap Liabilities Liabilities USD 21.20M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 367.65M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap LiabilitiesCurrent Liabilities, Current USD 19.03M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap LongTermDebt Long-term Debt USD 7.06M 2025-03-31 2025 Q1 10-Q 2025-05-06 0000950170-25-064552
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 2.00M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 2.00M 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042759
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 500,000 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-213466
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 0 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap LongTermInvestments Long-term Investments USD 100,000 2026-06-30 2026 Q2 10-Q 2026-08-05 0001193125-26-335407
us-gaap MarketableSecurities Marketable Securities USD 68.68M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 230.97M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 68.70M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 141.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -203.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -74.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -81.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 10.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap OperatingExpenses Operating Expenses USD 97.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -92.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 600,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 2.73M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 719,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 2.01M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap OperatingLeasePayments Operating Lease, Payments USD 400,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 2.48M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.116 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 402,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 305,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD 4,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax USD -724,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 35,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -1.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -1.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap PaymentsForProceedsFromInvestments Payments for (Proceeds from) Investments USD 100,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042759
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 102,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 758,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 344.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 372,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 10.85M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 23.50M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042759
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 17.16M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 12.50M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042759
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 141.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 5.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -81.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 1.82M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.13M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap RepaymentsOfDebt Repayments of Debt USD 2.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 75.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap RestrictedCash Restricted Cash USD 0 2025-03-31 2025 Q1 10-Q 2025-05-06 0000950170-25-064552
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 3.31M 2023-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042759
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -415.27M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 5.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 13.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.014 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.039 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 2.06M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-270012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 10.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 18,471 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 10 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 15.3 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 8.23M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 9.06M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 10.19 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 3.80M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 4.57M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 9.03 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 6.83 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 18.91 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 346.45M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.224 2024-09-17 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 765,802 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 342.83M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 98,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 984,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 131.86M 2023-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042759
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042759
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 31.63M 2023-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042759
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042759
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042759
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 148,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 1.03M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 67,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042759
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 0 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 19.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120873
us-gaap VariableLeasePayment Variable Lease, Payment USD 400,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 164,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 44.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 44.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450023

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →